105 related articles for article (PubMed ID: 338514)
21. Circulating immune complexes after renal transplantation. Correlation of increased 125I-Clq binding activity with acute rejection characterized by fibrin deposition in the kidney.
Ooi YM; Ooi BS; Vallota EH; First MR; Pollak VE
J Clin Invest; 1977 Sep; 60(3):611-9. PubMed ID: 330564
[TBL] [Abstract][Full Text] [Related]
22. Immune complexes in patients with drug eruptions: the relationship between skin lesions and circulating immune complexes.
Yanase K; Imamura S
Clin Exp Immunol; 1980 Sep; 41(3):471-7. PubMed ID: 6449338
[TBL] [Abstract][Full Text] [Related]
23. [Circulating immune complexes in malignant tumors].
Savina NP
Sov Med; 1989; (8):8-10. PubMed ID: 2814673
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of the interaction between immune complex and C1q complement subcomponent. The role of interdomain interactions in rabbit IgG in binding of C1q to immune precipitates.
Vonderviszt F; Török J; Lakatos S; Kilár F; Závodszky P
Biochem J; 1987 Apr; 243(2):449-55. PubMed ID: 3498482
[TBL] [Abstract][Full Text] [Related]
25. C1q-binding substances in peripheral lymph in bronchial carcinoma.
Heier HE; Sokolowski JA; Solheim OP
Lymphology; 1978 Dec; 11(4):170-3. PubMed ID: 739789
[TBL] [Abstract][Full Text] [Related]
26. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
27. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
[TBL] [Abstract][Full Text] [Related]
28. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
[TBL] [Abstract][Full Text] [Related]
29. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
[TBL] [Abstract][Full Text] [Related]
30. Circulating immune complexes in rats bearing chemically induced tumors. I. Sequential determination during the growth of tumours at various body sites.
Höffken K; Price MR; McLaughlin PJ; Moore VE; Baldwin RW
Int J Cancer; 1978 Apr; 21(4):496-504. PubMed ID: 208985
[TBL] [Abstract][Full Text] [Related]
31. Relationship of levels of circulating immune complexes to histologic patterns of nephritis: a comparative study of membranous glomerulonephropathy and diffuse proliferative glomerulonephritis.
Ooi YM; Ooi BS; Pollak VE
J Lab Clin Med; 1977 Nov; 90(5):891-8. PubMed ID: 908876
[TBL] [Abstract][Full Text] [Related]
32. Immunoglobulin complexes in sera of patients with malignancy.
Samayoa EA; McDuffie FC; Nelson AM; Go VL; Luthra HS; Brumfield HW
Int J Cancer; 1977 Jan; 19(1):12-7. PubMed ID: 832917
[TBL] [Abstract][Full Text] [Related]
33. Circulating immune complexes in patients with neoplastic disorders.
Yoshida R; Zawadzki ZA
Oncology; 1980; 37(3):152-6. PubMed ID: 7360487
[TBL] [Abstract][Full Text] [Related]
34. The use of TNP-conjugated polyacrylamide beads in a C1q binding inhibition test for circulating immune complexes.
Schmidt R; Walther S; Sodomann CP
Immunobiology; 1982; 162(2):153-64. PubMed ID: 6981581
[TBL] [Abstract][Full Text] [Related]
35. Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding tests.
Rossen RD; Zubler RH; Day NK; Reisberg MA; Morgan AC; Gutterman JU; Hersh EM
J Lab Clin Med; 1978 Feb; 91(2):191-204. PubMed ID: 413872
[TBL] [Abstract][Full Text] [Related]
36. Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome.
Starkebaum G; Arend WP; Nardella FA; Gavin SE
J Lab Clin Med; 1980 Aug; 96(2):238-51. PubMed ID: 6772719
[TBL] [Abstract][Full Text] [Related]
37. Immune complexes in human malignant tumours. A review.
Segal-Eiras A; Croce MV
Allergol Immunopathol (Madr); 1984; 12(3):225-32. PubMed ID: 6382986
[TBL] [Abstract][Full Text] [Related]
38. Serological evidence of an association between chlamydial infections and malignant lymphomas.
Anttila TI; Lehtinen T; Leinonen M; Bloigu A; Koskela P; Lehtinen M; Saikku P
Br J Haematol; 1998 Oct; 103(1):150-6. PubMed ID: 9792302
[TBL] [Abstract][Full Text] [Related]
39. The detection of circulating immune complexes containing immunoglobulin G.
Valentijn RM; van Es LA; Westedt ML; Daha MR
J Clin Lab Immunol; 1984 Jun; 14(2):73-9. PubMed ID: 6748049
[TBL] [Abstract][Full Text] [Related]
40. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
